MedPath
HSA Approval

APO-TICLOPIDINE TABLET 250 mg

SIN11692P

APO-TICLOPIDINE TABLET 250 mg

APO-TICLOPIDINE TABLET 250 mg

October 5, 2001

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AC05

ticlopidine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

TICLOPIDINE HCl

250 mg

Ticlopidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-TICLOPIDINE TABLET 250 mg - HSA Approval | MedPath